Mood Disorders

This is the extra table for "Interest Grows in Treatment of Mood Disorders by Classic Psychedelics."

This diet was associated with significant reductions in variability of symptoms in patients with bipolar disorder.

What is the clinician’s role in reversing stigma for better outcomes?

What are the differences in epidemiological and clinical characteristics of bipolar disorder between the sexes?

Up to 20% of patients with bipolar disorder have 4 or more medications, so it is important to be aware of these common drug-drug interactions.

Are you taking your medication? Researchers performed a nationwide register-based study of primary antipsychotic nonadherence in schizophrenia.

What do you and your patients need to know about adjusting to daylight savings time?

Associated outcomes include higher rates of psychiatric hospitalization and mortality.

Have you had difficulty with differential diagnosis when patients have manic symptoms and psychosis? One doctor discusses the related DSM-5 criteria changes and some of their implications for psychopharmacology.

Psychiatric Times featured a wide variety of psychiatric issues in this year’s CMEs.

This infrequent, but important, toxic effect of lithium deserves increased awareness.

Are your patients feeling stressed out? Here are 10 tips to share with them for a less stressful holiday season.

Should we go up? Researchers performed a dose-response meta-analysis of randomized controlled trials in acute phase schizophrenia.

How can transcranial magnetic stimulation help patients with treatment-resistant depression?

How does schizophrenia as a pathology differ from normal human experience?

What is the connection between inflammation and mood disorders?

How do you manage the 4 most common adverse effects of antipsychotic medications?

Results suggest that psilocybin therapy may prove to be helpful in improving quality of life for patients with cancer.

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

In older adults with bipolar disorder, what evidence is there to guide treatment?

A patient presents with multiple substance use disorders super-imposed on mood and anxiety disorders. Where does a clinician even begin?

What are the risk factors for and prevalence overweight and obesity in patients with first-episode drug-naïve major depressive disorder?

Doctor, can I have an extra cup of caffeine? Researchers performed a systematic review of studies of caffeine consumption and clinical symptoms in patients with bipolar disorder.

What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.

Is depression the same today as it was in the 17th century? Is it the same thing in Nigeria as it is in the United States? One of the foremost historians of psychiatry weighs in.

Sleep problems are understudied, underdiagnosed, and undertreated.

In this conversation, a former APA president discusses mystical and meditative experiences, reconciling psychoanalysis and neuroscience, and tensions surrounding the medical model.

What treatments could handle both psychiatric emergencies and long-standings mental health conditions—in a hurry?

One doctor at the APA Virtual meeting explains how ketamine can rebuild spine and synaptic proteins in the brain, but may be difficult to actually prescribe to patients.